Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02492997 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference
A NA study, sponsored by Venus Concept.
- Terminated
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02492997 is a NA study that was terminated before completion, run by Venus Concept. The registered enrollment target is 44 participants.
The verdict
NCT02492997, a NA study, was terminated before completion, sponsored by Venus Concept.
- TERMINATED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The octipolar applicator is intended for circumference reduction treatment by reduction of adipose size and enhancement of collagen synthesis as the result thermal and non-thermal collagen stimulation. This trial is intended to evaluate the effect of radio frequency (RF) and pulsed electromagnetic fields (PEMF) treatment on circumference reduction.
Interventions
- DEVICE Venus Versa
- OTHER Glycerine gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-05-14 |
| Est. Completion | 2016-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02492997
The ClinicalTrials.gov registry entry for NCT02492997 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Venus Versa is the first listed.
NCT02492997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02492997 about?
NCT02492997 is a clinical study titled "Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference". The octipolar applicator is intended for circumference reduction treatment by reduction of adipose size and enhancement of collagen synthesis as the result thermal and non-thermal collagen stimulation. This trial is intended to evaluate the effect of radio frequency (RF) and pulsed electromagnetic f...
What is the current status of trial NCT02492997?
This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2015-05-14. Estimated completion is 2016-10-31.
What interventions are being tested in trial NCT02492997?
The interventions under investigation include: Venus Versa (DEVICE), Glycerine gel (OTHER).
Who is sponsoring clinical trial NCT02492997?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.